ERJ Open Research

Papers
(The H4-Index of ERJ Open Research is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Dual CFTR modulator therapy efficacy in the real world: lessons for the future256
Long-term incident severe outcomes in a prospective cohort of non-obese obstructive sleep apnoea patients free of comorbidities at inclusion62
Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturation60
Williams–Campbell syndrome case series and discordant twins45
The NEuroCOUGH Chronic Cough Registry: a protocol for a pan-European observational study42
Artificial intelligence augmentation raises questions about the future of bronchoscopy37
Diagnostic delay in bronchiectasis: an Italian perspective37
Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality36
Proteins associated with preserved ratio impaired spirometry36
High-frequency percussive ventilation in acute respiratory failure34
Serotype distribution and coverage by pneumococcal vaccines in hospitalized adults with pneumococcal pneumonia in Germany33
Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis32
“Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.” Michael R. Loebinger, Stefano Aliberti, Charles Haw31
Extracellular iron and the lung microbiome in smoking and COPD30
Phase III AIRTIVITY™ study design – verducatib (BI 1291583) in people with bronchiectasis30
Global survey of physician testing practices for nontuberculous mycobacteria30
Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance29
Slow deep breathing reduces muscle sympathetic nerve activity and improves breathing efficiency in pulmonary hypertension29
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry29
Anodal transcranial direct current stimulation over the right primary somatosensory cortex increases cough reflex sensitivity: a pilot randomised controlled crossover trial27
The noninvasive ventilation outcomes score in patients requiring NIV for COPD exacerbation without prior evidence of airflow obstruction27
Increased loop gain and upper airway collapsibility among smoking patients with obstructive sleep apnoea27
Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis27
Myostatin/Smad2/Smad3 pathway define a differential clinical phenotype in COPD-associated sarcopenia27
ROHHAD syndrome in an adult: presence of ZSCAN1 antibodies26
Association of patient-reported outcome measures with lung function and mortality in fibrotic interstitial lung disease: a prospective cohort study26
A comprehensive evaluation of murine and humanex vivocultured alveolar macrophages26
3.593355178833